Share Price and Basic Stock Data
Last Updated: November 3, 2025, 9:47 pm
| PEG Ratio | -2.51 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Prolife Industries Ltd operates in the Dyes & Pigments sector and reported a current share price of ₹93.8 with a market capitalization of ₹38.4 Cr. Over the past few years, the company’s revenue trajectory has displayed notable fluctuations. Sales stood at ₹78.15 Cr for the fiscal year ending March 2023, marking an increase from ₹73.08 Cr in FY 2022. However, projections for FY 2024 and FY 2025 indicated a decline to ₹56.81 Cr and ₹55.35 Cr respectively. Quarterly sales figures also reflect this volatility, with a peak of ₹42.96 Cr recorded in September 2022, followed by a decrease to ₹29.86 Cr in September 2023. The company’s operational prowess is evident in its ability to generate revenue despite economic headwinds, although the decline in recent quarters raises questions about future growth. The overall sales pattern suggests that while the company has managed to grow its top line in the past, sustaining this growth remains a challenge.
Profitability and Efficiency Metrics
Prolife Industries Ltd’s profitability metrics reveal a mixed performance. The net profit for FY 2023 was ₹6.91 Cr, up from ₹4.30 Cr in FY 2022, but projections for FY 2024 and FY 2025 show a decline to ₹4.68 Cr. The operating profit margin (OPM) stood at a modest 1.98% in the latest reported figures, significantly lower than the OPM of 20.49% in March 2019. The company’s return on equity (ROE) was reported at 10.28%, while the return on capital employed (ROCE) was at 13.67%, indicating reasonable efficiency in generating profits from shareholders’ equity and capital. Furthermore, the interest coverage ratio (ICR) stood impressively at 23.12, suggesting strong capability in meeting interest obligations. However, the declining OPM and net profit projections highlight potential inefficiencies and cost pressures that the company may face in the near future, potentially impacting its profitability.
Balance Sheet Strength and Financial Ratios
Prolife Industries Ltd exhibits a solid financial position characterized by low debt levels and substantial reserves. As of March 2025, the company’s total borrowings were reported at ₹2.58 Cr, reflecting a long-term debt-to-equity ratio of just 0.05, indicating minimal reliance on debt financing. The reserves stood at ₹41.38 Cr, showcasing a robust capital buffer. The current ratio was reported at 6.99, significantly above the typical industry benchmark of 1.5, suggesting strong liquidity to meet short-term obligations. Additionally, the price-to-book value (P/BV) ratio was recorded at 1.98x, indicating that the stock is valued reasonably compared to its book value. However, the enterprise value (EV) of ₹75.27 Cr relative to net operating revenue reflects a valuation that may warrant close scrutiny, especially in light of declining sales forecasts. Overall, the financial ratios indicate a well-capitalized company but raise concerns about future revenue generation.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Prolife Industries Ltd reveals a stable ownership structure, with promoters holding a significant 73.74% stake, which has remained unchanged over the past reporting periods. The public holds the remaining 26.26%, indicating a lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs), which may limit liquidity and market interest. The number of shareholders has increased from 382 in September 2023 to 477 in March 2025, reflecting growing retail investor participation. This uptick in shareholder numbers could signal increased confidence in the company’s operations or potential for growth, despite the recent decline in profitability. However, the absence of institutional backing raises concerns about volatility during market fluctuations. The concentration of ownership among promoters might also lead to governance-related risks, which could impact investor sentiment if not addressed adequately.
Outlook, Risks, and Final Insight
Looking ahead, Prolife Industries Ltd faces a landscape of both opportunities and challenges. The company’s strong balance sheet, characterized by low debt and healthy reserves, positions it well to weather economic fluctuations. However, the declining sales and profitability metrics signal potential headwinds, particularly in sustaining growth in a competitive market. Risks include reliance on a limited customer base and potential cost pressures impacting margins. A focus on operational efficiency and exploring new market opportunities could mitigate some of these risks. The absence of institutional investors may also pose challenges in raising capital for expansion. In conclusion, while Prolife Industries Ltd holds inherent strengths in its financial structure, addressing the declining trend in revenue and profitability will be crucial for maintaining investor confidence and ensuring long-term sustainability in the dyes and pigments industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Prolife Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Deepak Chemtex Ltd | 146 Cr. | 134 | 175/93.5 | 14.5 | 49.3 | 0.00 % | 28.1 % | 20.9 % | 10.0 |
| Prolife Industries Ltd | 37.2 Cr. | 91.0 | 361/86.6 | 7.96 | 111 | 0.33 % | 14.4 % | 10.8 % | 10.0 |
| Industry Average | 146.00 Cr | 112.50 | 11.23 | 80.15 | 0.17% | 21.25% | 15.85% | 10.00 |
Quarterly Result
| Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.91 | 23.27 | 27.18 | 33.33 | 40.26 | 34.89 | 38.31 | 42.96 | 35.36 | 29.86 | 26.96 | 26.68 | 28.79 |
| Expenses | 12.65 | 21.07 | 23.86 | 29.09 | 36.31 | 31.05 | 36.18 | 38.44 | 31.15 | 22.93 | 22.08 | 21.58 | 28.22 |
| Operating Profit | 3.26 | 2.20 | 3.32 | 4.24 | 3.95 | 3.84 | 2.13 | 4.52 | 4.21 | 6.93 | 4.88 | 5.10 | 0.57 |
| OPM % | 20.49% | 9.45% | 12.21% | 12.72% | 9.81% | 11.01% | 5.56% | 10.52% | 11.91% | 23.21% | 18.10% | 19.12% | 1.98% |
| Other Income | -0.14 | 0.68 | 1.10 | 0.23 | 0.39 | 0.51 | 1.11 | 0.85 | 1.33 | 0.51 | 1.08 | 0.45 | 1.63 |
| Interest | 0.51 | 0.49 | 0.10 | 0.29 | 0.20 | 0.25 | 0.21 | 0.39 | 0.03 | 0.20 | 0.13 | 0.18 | 0.15 |
| Depreciation | 0.58 | 0.51 | 0.52 | 0.50 | 0.43 | 0.48 | 0.68 | 0.62 | 0.63 | 0.62 | 0.59 | 0.56 | 0.54 |
| Profit before tax | 2.03 | 1.88 | 3.80 | 3.68 | 3.71 | 3.62 | 2.35 | 4.36 | 4.88 | 6.62 | 5.24 | 4.81 | 1.51 |
| Tax % | 23.65% | 29.79% | 28.42% | 26.09% | 25.34% | 20.72% | 39.15% | 20.87% | 28.89% | 25.08% | 27.48% | 21.83% | 38.41% |
| Net Profit | 1.55 | 1.32 | 2.72 | 2.73 | 2.77 | 2.87 | 1.43 | 3.45 | 3.46 | 4.96 | 3.80 | 3.75 | 0.92 |
| EPS in Rs | 3.79 | 3.22 | 6.64 | 6.67 | 6.77 | 7.01 | 3.49 | 8.43 | 8.45 | 12.11 | 9.28 | 9.16 | 2.25 |
Last Updated: May 31, 2025, 8:03 am
Below is a detailed analysis of the quarterly data for Prolife Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 28.79 Cr.. The value appears strong and on an upward trend. It has increased from 26.68 Cr. (Sep 2024) to 28.79 Cr., marking an increase of 2.11 Cr..
- For Expenses, as of Mar 2025, the value is 28.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.58 Cr. (Sep 2024) to 28.22 Cr., marking an increase of 6.64 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 5.10 Cr. (Sep 2024) to 0.57 Cr., marking a decrease of 4.53 Cr..
- For OPM %, as of Mar 2025, the value is 1.98%. The value appears to be declining and may need further review. It has decreased from 19.12% (Sep 2024) to 1.98%, marking a decrease of 17.14%.
- For Other Income, as of Mar 2025, the value is 1.63 Cr.. The value appears strong and on an upward trend. It has increased from 0.45 Cr. (Sep 2024) to 1.63 Cr., marking an increase of 1.18 Cr..
- For Interest, as of Mar 2025, the value is 0.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.18 Cr. (Sep 2024) to 0.15 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Mar 2025, the value is 0.54 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.56 Cr. (Sep 2024) to 0.54 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.51 Cr.. The value appears to be declining and may need further review. It has decreased from 4.81 Cr. (Sep 2024) to 1.51 Cr., marking a decrease of 3.30 Cr..
- For Tax %, as of Mar 2025, the value is 38.41%. The value appears to be increasing, which may not be favorable. It has increased from 21.83% (Sep 2024) to 38.41%, marking an increase of 16.58%.
- For Net Profit, as of Mar 2025, the value is 0.92 Cr.. The value appears to be declining and may need further review. It has decreased from 3.75 Cr. (Sep 2024) to 0.92 Cr., marking a decrease of 2.83 Cr..
- For EPS in Rs, as of Mar 2025, the value is 2.25. The value appears to be declining and may need further review. It has decreased from 9.16 (Sep 2024) to 2.25, marking a decrease of 6.91.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:36 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.95 | 19.58 | 22.19 | 27.14 | 27.20 | 29.58 | 50.38 | 73.50 | 73.08 | 78.15 | 56.81 | 55.35 |
| Expenses | 17.49 | 17.76 | 20.39 | 24.60 | 23.65 | 25.38 | 44.82 | 65.28 | 67.10 | 69.41 | 45.00 | 49.67 |
| Operating Profit | 1.46 | 1.82 | 1.80 | 2.54 | 3.55 | 4.20 | 5.56 | 8.22 | 5.98 | 8.74 | 11.81 | 5.68 |
| OPM % | 7.70% | 9.30% | 8.11% | 9.36% | 13.05% | 14.20% | 11.04% | 11.18% | 8.18% | 11.18% | 20.79% | 10.26% |
| Other Income | 0.10 | 0.31 | 0.45 | 0.10 | 0.27 | 0.46 | 1.78 | 0.62 | 1.63 | 2.18 | 1.59 | 2.08 |
| Interest | 0.87 | 1.11 | 1.01 | 0.84 | 0.84 | 0.91 | 0.63 | 0.52 | 0.48 | 0.43 | 0.33 | 0.34 |
| Depreciation | 0.29 | 0.40 | 0.42 | 0.47 | 0.89 | 0.93 | 1.03 | 0.93 | 1.16 | 1.25 | 1.21 | 1.10 |
| Profit before tax | 0.40 | 0.62 | 0.82 | 1.33 | 2.09 | 2.82 | 5.68 | 7.39 | 5.97 | 9.24 | 11.86 | 6.32 |
| Tax % | 45.00% | 37.10% | 35.37% | 33.83% | 28.23% | 28.01% | 28.87% | 25.58% | 27.97% | 25.11% | 26.14% | 25.79% |
| Net Profit | 0.22 | 0.40 | 0.53 | 0.87 | 1.50 | 2.04 | 4.04 | 5.50 | 4.30 | 6.91 | 8.76 | 4.68 |
| EPS in Rs | 1.47 | 2.68 | 3.55 | 2.13 | 3.66 | 4.98 | 9.87 | 13.43 | 10.50 | 16.88 | 21.40 | 11.43 |
| Dividend Payout % | 20.32% | 8.94% | 7.03% | 9.40% | 6.82% | 6.01% | 3.04% | 2.23% | 2.85% | 1.78% | 2.33% | 2.62% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 81.82% | 32.50% | 64.15% | 72.41% | 36.00% | 98.04% | 36.14% | -21.82% | 60.70% | 26.77% | -46.58% |
| Change in YoY Net Profit Growth (%) | 0.00% | -49.32% | 31.65% | 8.26% | -36.41% | 62.04% | -61.90% | -57.96% | 82.52% | -33.92% | -73.35% |
Prolife Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 2% |
| 3 Years: | -9% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 3% |
| 3 Years: | 3% |
| TTM: | -47% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | -6% |
| 1 Year: | -50% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 12:45 pm
Balance Sheet
Last Updated: October 10, 2025, 2:47 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.49 | 1.49 | 1.49 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
| Reserves | 1.04 | 1.53 | 2.10 | 4.59 | 6.00 | 8.03 | 11.92 | 17.30 | 21.48 | 28.27 | 36.90 | 41.38 |
| Borrowings | 9.60 | 10.10 | 8.61 | 5.07 | 4.82 | 7.15 | 7.71 | 5.49 | 4.71 | 1.92 | 3.81 | 2.58 |
| Other Liabilities | 4.07 | 4.57 | 3.84 | 4.77 | 6.22 | 7.42 | 11.94 | 21.75 | 25.15 | 6.88 | 7.12 | 5.27 |
| Total Liabilities | 16.20 | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 |
| Fixed Assets | 2.29 | 2.73 | 3.21 | 8.11 | 9.56 | 10.04 | 9.60 | 9.34 | 11.43 | 11.36 | 11.29 | 10.51 |
| CWIP | 0.13 | 0.13 | 0.57 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.86 | 2.87 | 2.81 | 1.52 | 1.77 | 1.76 | 1.22 | 1.22 | 1.22 | 1.21 | 1.21 | 1.21 |
| Other Assets | 10.92 | 11.96 | 9.45 | 8.36 | 9.80 | 14.89 | 24.84 | 38.07 | 42.78 | 28.59 | 39.42 | 41.60 |
| Total Assets | 16.20 | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 |
Below is a detailed analysis of the balance sheet data for Prolife Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 4.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.09 Cr..
- For Reserves, as of Mar 2025, the value is 41.38 Cr.. The value appears strong and on an upward trend. It has increased from 36.90 Cr. (Mar 2024) to 41.38 Cr., marking an increase of 4.48 Cr..
- For Borrowings, as of Mar 2025, the value is 2.58 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 3.81 Cr. (Mar 2024) to 2.58 Cr., marking a decrease of 1.23 Cr..
- For Other Liabilities, as of Mar 2025, the value is 5.27 Cr.. The value appears to be improving (decreasing). It has decreased from 7.12 Cr. (Mar 2024) to 5.27 Cr., marking a decrease of 1.85 Cr..
- For Total Liabilities, as of Mar 2025, the value is 53.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 51.92 Cr. (Mar 2024) to 53.32 Cr., marking an increase of 1.40 Cr..
- For Fixed Assets, as of Mar 2025, the value is 10.51 Cr.. The value appears to be declining and may need further review. It has decreased from 11.29 Cr. (Mar 2024) to 10.51 Cr., marking a decrease of 0.78 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 1.21 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.21 Cr..
- For Other Assets, as of Mar 2025, the value is 41.60 Cr.. The value appears strong and on an upward trend. It has increased from 39.42 Cr. (Mar 2024) to 41.60 Cr., marking an increase of 2.18 Cr..
- For Total Assets, as of Mar 2025, the value is 53.32 Cr.. The value appears strong and on an upward trend. It has increased from 51.92 Cr. (Mar 2024) to 53.32 Cr., marking an increase of 1.40 Cr..
Notably, the Reserves (41.38 Cr.) exceed the Borrowings (2.58 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -8.14 | -8.28 | -6.81 | -2.53 | -1.27 | -2.95 | -2.15 | 2.73 | 1.27 | 6.82 | 8.00 | 3.10 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 53.16 | 62.64 | 63.66 | 57.56 | 38.11 | 100.44 | 52.16 | 78.46 | 83.76 | 49.55 | 34.44 | 55.79 |
| Inventory Days | 162.19 | 170.77 | 69.16 | 43.03 | 65.17 | 37.05 | 62.59 | 52.32 | 76.79 | 39.40 | 63.68 | 68.39 |
| Days Payable | 77.54 | 91.39 | 68.73 | 71.78 | 104.12 | 104.55 | 89.97 | 124.33 | 149.89 | 25.99 | 37.71 | 30.18 |
| Cash Conversion Cycle | 137.82 | 142.02 | 64.08 | 28.81 | -0.84 | 32.93 | 24.78 | 6.45 | 10.66 | 62.96 | 60.41 | 94.00 |
| Working Capital Days | 98.62 | 87.61 | 40.46 | 54.06 | 18.12 | 54.91 | 0.07 | 8.94 | 19.58 | 57.54 | 28.98 | 70.10 |
| ROCE % | 10.63% | 13.70% | 14.93% | 16.57% | 20.31% | 21.83% | 29.03% | 30.83% | 22.57% | 29.96% | 30.83% | 14.35% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 |
| Diluted EPS (Rs.) | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 |
| Cash EPS (Rs.) | 14.11 | 24.36 | 19.94 | 13.33 | 15.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 111.07 | 100.14 | 79.04 | 62.46 | 52.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 111.07 | 100.14 | 79.04 | 62.46 | 52.25 |
| Dividend / Share (Rs.) | 0.30 | 0.50 | 0.30 | 0.30 | 0.30 |
| Revenue From Operations / Share (Rs.) | 135.49 | 138.79 | 191.28 | 178.80 | 179.74 |
| PBDIT / Share (Rs.) | 18.93 | 32.74 | 26.65 | 18.53 | 21.53 |
| PBIT / Share (Rs.) | 16.25 | 29.77 | 23.59 | 15.71 | 19.25 |
| PBT / Share (Rs.) | 15.43 | 28.96 | 22.55 | 14.59 | 18.05 |
| Net Profit / Share (Rs.) | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 |
| PBDIT Margin (%) | 13.97 | 23.58 | 13.93 | 10.36 | 11.98 |
| PBIT Margin (%) | 11.99 | 21.45 | 12.33 | 8.78 | 10.71 |
| PBT Margin (%) | 11.39 | 20.86 | 11.79 | 8.15 | 10.04 |
| Net Profit Margin (%) | 8.43 | 15.41 | 8.82 | 5.87 | 7.47 |
| Return on Networth / Equity (%) | 10.28 | 21.36 | 21.36 | 16.82 | 25.70 |
| Return on Capital Employeed (%) | 13.67 | 26.89 | 26.13 | 20.71 | 29.84 |
| Return On Assets (%) | 8.77 | 16.87 | 16.79 | 7.76 | 11.30 |
| Long Term Debt / Equity (X) | 0.05 | 0.09 | 0.12 | 0.19 | 0.21 |
| Total Debt / Equity (X) | 0.05 | 0.09 | 0.05 | 0.18 | 0.25 |
| Asset Turnover Ratio (%) | 1.05 | 1.22 | 1.62 | 1.41 | 1.75 |
| Current Ratio (X) | 6.99 | 4.95 | 4.28 | 1.22 | 1.12 |
| Quick Ratio (X) | 5.56 | 4.11 | 2.90 | 0.74 | 0.76 |
| Inventory Turnover Ratio (X) | 9.01 | 5.57 | 5.93 | 5.78 | 7.85 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 1.40 | 1.77 | 2.85 | 2.23 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 1.23 | 1.50 | 2.24 | 1.91 |
| Earning Retention Ratio (%) | 0.00 | 98.60 | 98.23 | 97.15 | 97.77 |
| Cash Earning Retention Ratio (%) | 0.00 | 98.77 | 98.50 | 97.76 | 98.09 |
| Interest Coverage Ratio (X) | 23.12 | 40.07 | 25.77 | 16.53 | 17.93 |
| Interest Coverage Ratio (Post Tax) (X) | 14.95 | 27.19 | 17.33 | 10.37 | 12.19 |
| Enterprise Value (Cr.) | 75.27 | 68.98 | 86.71 | 71.22 | 25.38 |
| EV / Net Operating Revenue (X) | 1.36 | 1.21 | 1.11 | 0.97 | 0.34 |
| EV / EBITDA (X) | 9.71 | 5.15 | 7.95 | 9.39 | 2.88 |
| MarketCap / Net Operating Revenue (X) | 1.62 | 1.53 | 1.10 | 0.92 | 0.28 |
| Retention Ratios (%) | 0.00 | 98.59 | 98.22 | 97.14 | 97.76 |
| Price / BV (X) | 1.98 | 2.12 | 2.67 | 2.65 | 0.96 |
| Price / Net Operating Revenue (X) | 1.62 | 1.53 | 1.10 | 0.92 | 0.28 |
| EarningsYield | 0.05 | 0.10 | 0.08 | 0.06 | 0.26 |
After reviewing the key financial ratios for Prolife Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 11.43, marking a decrease of 9.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 11.43, marking a decrease of 9.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.11. This value is within the healthy range. It has decreased from 24.36 (Mar 24) to 14.11, marking a decrease of 10.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.07. It has increased from 100.14 (Mar 24) to 111.07, marking an increase of 10.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.07. It has increased from 100.14 (Mar 24) to 111.07, marking an increase of 10.93.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.30, marking a decrease of 0.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 135.49. It has decreased from 138.79 (Mar 24) to 135.49, marking a decrease of 3.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.93. This value is within the healthy range. It has decreased from 32.74 (Mar 24) to 18.93, marking a decrease of 13.81.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.25. This value is within the healthy range. It has decreased from 29.77 (Mar 24) to 16.25, marking a decrease of 13.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.43. This value is within the healthy range. It has decreased from 28.96 (Mar 24) to 15.43, marking a decrease of 13.53.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 11.43, marking a decrease of 9.97.
- For PBDIT Margin (%), as of Mar 25, the value is 13.97. This value is within the healthy range. It has decreased from 23.58 (Mar 24) to 13.97, marking a decrease of 9.61.
- For PBIT Margin (%), as of Mar 25, the value is 11.99. This value is within the healthy range. It has decreased from 21.45 (Mar 24) to 11.99, marking a decrease of 9.46.
- For PBT Margin (%), as of Mar 25, the value is 11.39. This value is within the healthy range. It has decreased from 20.86 (Mar 24) to 11.39, marking a decrease of 9.47.
- For Net Profit Margin (%), as of Mar 25, the value is 8.43. This value is within the healthy range. It has decreased from 15.41 (Mar 24) to 8.43, marking a decrease of 6.98.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.28. This value is below the healthy minimum of 15. It has decreased from 21.36 (Mar 24) to 10.28, marking a decrease of 11.08.
- For Return on Capital Employeed (%), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 26.89 (Mar 24) to 13.67, marking a decrease of 13.22.
- For Return On Assets (%), as of Mar 25, the value is 8.77. This value is within the healthy range. It has decreased from 16.87 (Mar 24) to 8.77, marking a decrease of 8.10.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.05, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.09 (Mar 24) to 0.05, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.05. It has decreased from 1.22 (Mar 24) to 1.05, marking a decrease of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 6.99. This value exceeds the healthy maximum of 3. It has increased from 4.95 (Mar 24) to 6.99, marking an increase of 2.04.
- For Quick Ratio (X), as of Mar 25, the value is 5.56. This value exceeds the healthy maximum of 2. It has increased from 4.11 (Mar 24) to 5.56, marking an increase of 1.45.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.01. This value exceeds the healthy maximum of 8. It has increased from 5.57 (Mar 24) to 9.01, marking an increase of 3.44.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.40 (Mar 24) to 0.00, marking a decrease of 1.40.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.23 (Mar 24) to 0.00, marking a decrease of 1.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.60 (Mar 24) to 0.00, marking a decrease of 98.60.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.77 (Mar 24) to 0.00, marking a decrease of 98.77.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 23.12. This value is within the healthy range. It has decreased from 40.07 (Mar 24) to 23.12, marking a decrease of 16.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.95. This value is within the healthy range. It has decreased from 27.19 (Mar 24) to 14.95, marking a decrease of 12.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 75.27. It has increased from 68.98 (Mar 24) to 75.27, marking an increase of 6.29.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 1.21 (Mar 24) to 1.36, marking an increase of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 9.71. This value is within the healthy range. It has increased from 5.15 (Mar 24) to 9.71, marking an increase of 4.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 1.53 (Mar 24) to 1.62, marking an increase of 0.09.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 98.59 (Mar 24) to 0.00, marking a decrease of 98.59.
- For Price / BV (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.98, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 1.53 (Mar 24) to 1.62, marking an increase of 0.09.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 24) to 0.05, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Prolife Industries Ltd:
- Net Profit Margin: 8.43%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 13.67% (Industry Average ROCE: 21.25%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.28% (Industry Average ROE: 15.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 14.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 7.96 (Industry average Stock P/E: 11.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.43%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | No. 213, G.I.D.C., Panoli, Ankleshwar Gujarat 394116 | info@prolifeindustries.in http://www.prolifeindustries.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Karan M Jolly | Managing Director |
| Mrs. Anureet Kaur Jolly | Director |
| Mr. Siddharth Raghuvanshi | Director |
| Mr. Veljibhai K Patel | Director |
| Mr. Dharmendra Pushkarna | Independent Director |
| Mr. Keshavkumar B Singh | Independent Director |
FAQ
What is the intrinsic value of Prolife Industries Ltd?
Prolife Industries Ltd's intrinsic value (as of 11 November 2025) is 76.59 which is 15.84% lower the current market price of 91.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 37.2 Cr. market cap, FY2025-2026 high/low of 361/86.6, reserves of ₹41.38 Cr, and liabilities of 53.32 Cr.
What is the Market Cap of Prolife Industries Ltd?
The Market Cap of Prolife Industries Ltd is 37.2 Cr..
What is the current Stock Price of Prolife Industries Ltd as on 11 November 2025?
The current stock price of Prolife Industries Ltd as on 11 November 2025 is 91.0.
What is the High / Low of Prolife Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Prolife Industries Ltd stocks is 361/86.6.
What is the Stock P/E of Prolife Industries Ltd?
The Stock P/E of Prolife Industries Ltd is 7.96.
What is the Book Value of Prolife Industries Ltd?
The Book Value of Prolife Industries Ltd is 111.
What is the Dividend Yield of Prolife Industries Ltd?
The Dividend Yield of Prolife Industries Ltd is 0.33 %.
What is the ROCE of Prolife Industries Ltd?
The ROCE of Prolife Industries Ltd is 14.4 %.
What is the ROE of Prolife Industries Ltd?
The ROE of Prolife Industries Ltd is 10.8 %.
What is the Face Value of Prolife Industries Ltd?
The Face Value of Prolife Industries Ltd is 10.0.